Basking Ridge, NJ, United States of America

Tien-Jung Lee

This inventor holds 1 USPTO granted patent. Top assignee: Ethicon, Gmbh. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tien-Jung Lee. Retrieved from https://idiyas.com/inventor/tien-jung-lee-ftxkcp5f

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tien-Jung Lee: Inventor of an Expandable Hemostatic Tablet

Introduction

Tien-Jung Lee is an inventor associated with Basking Ridge, New Jersey, and Ethicon GmbH. His patent work addresses a medical technology designed to support bleeding control.

Latest Patents

Lee is associated with 1 patent, titled “Expandable Hemostatic Tablets Comprising Oxidized Regenerated Cellulose.” The invention describes compressed hemostatic tablets made from multilayer fibrous non-woven oxidized cellulose or oxidized regenerated cellulose, with a calcium salt. The tablets are designed to remain dimensionally stable after compression and rapidly expand when they contact blood or blood plasma. Some embodiments also include a multi-arm PEG-SG and are described as expanding several times their original length over periods ranging from seconds to minutes. The patent further describes effectiveness in hemostasis in heparinized blood.

Career Highlights

Lee’s listed patent reflects work on a compressed, expandable hemostatic material intended for medical use. The invention focuses on combining stable tablet form with rapid expansion upon exposure to blood.

Collaborations

Lee’s listed coworker is Yi-Lan Wang. The patent is associated with Ethicon GmbH.

Conclusion

Tien-Jung Lee’s patent work centers on an expandable oxidized-cellulose hemostatic tablet designed to support bleeding control upon contact with blood.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…